Crizotinib is made to treat a type of lung cancer that’s linked to certain gene changes, like ALK, ROS1, or MET. It stops these specific kinase proteins from working. You can get it in two doses: 200 mg or 250 mg in each capsule.
The usual dose is 250 mg, taken two times a day, and you can take it with or without food. It comes in bottles with 60 capsules each. It’s a targeted therapy, which means it targets the specific genetic changes in NSCLC cells.
It’s really important for patients with these genetic changes because it can help them live longer and feel better. Keeping an eye out for side effects and sticking to the treatment plan is key to getting the best results.
